You might also like
Tear-off pad on AML with FLT3 mutation
This tear-off pad has been created to provide clear explanations about FLT3-mutated AML for patients.
Find out more
ADMIRAL trial (2019)
Publication
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Find out moreThe role of Measurable Residual Disease (MRD) testing in the treatment of Acute Myeloide Leukemia (AML)
Video
In this video, experts Prof. Dr. Jacqueline Cloos (Amsterdam UMC, Amsterdam) and Dr. Peter Valk (Erasmus MC, Rotterdam), discuss the role of MRD testing in the treatment of AML. The aim of the video is to inform physicians and laboratory technicians that are involved in AML treatment about recent developments in the field, and help them to optimize diagnostics, treatment, and therapeutical outcomes.
Intended for: practitioners
Why: up-to-date knowledge
When: watch now
Language: Dutch with French subtitles
Duration: 70 minutes
MAT-BE-NON-2024-00054 - Latest update April 2024